Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa - Wikidata - awgldk - TriplyDB

Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa

Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa

http://www.wikidata.org/entity/Q35275146

about

Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine.Prospects and perspectives for development of a vaccine against herpes simplex virus infections.Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital model An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs.Anti-glycoprotein g antibodies of herpes simplex virus 2 contribute to complete protection after vaccination in mice and induce antibody-dependent cellular cytotoxicity and complement-mediated cytolysis Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans Genomic, phylogenetic, and recombinational characterization of herpes simplex virus 2 strains.Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread.A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus.The challenge of developing a herpes simplex virus 2 vaccine.Herpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections.Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells.Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge.Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses.Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs.Antibody-based concepts for multipurpose prevention technologies.HSV-2 vaccine: current status and insight into factors for developing an efficient vaccine.Rapid host immune response and viral dynamics in herpes simplex virus-2 infection.Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens.Overexpression and purification of HSV-2 glycoprotein D in suspension CHO cells with serum-free medium and immunogenicity analysis.Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Rese A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model.Efficient production of recombinant glycoprotein D of herpes simplex virus type 2 in Pichia pastoris and its protective efficacy against viral challenge in mice.DNA vaccine expressing herpes simplex virus 1 glycoprotein C and D protects mice against herpes simplex keratitis.Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection

P2860

Q34057952-F5EF0BD1-25C3-4EFA-BA3E-0E70CA021C00 Q34229689-7FDF311F-7782-45B3-A4A7-C2723A2FAB10 Q34431547-80CBFF86-9D27-4D30-95DF-E0804BFCD30E Q34447379-ADFFC168-7BFC-4869-812C-B9E11A8E229C Q34549656-233D3420-05BE-4A7A-93FF-67AD0C8C299A Q34580831-ECF2FB4F-BE26-496C-BC12-4144D2DF15C1 Q34593833-76150DC8-CF8D-41CF-8B6D-49FACF03A7EE Q35760461-74BDF421-10FC-4DA5-B572-75C4F78A9BBF Q35866976-03B38980-3B29-409E-BB65-422D052DD5CC Q35867958-FC130FB4-8C6F-4AE9-94DA-68BF6B476EB1 Q35914367-A24BC683-261F-427F-9B55-334E909AF21B Q35973512-1840F824-3C66-40C4-B705-BA91ECAD41B3 Q36553837-C0E2DA07-AD6A-4636-B5B6-0DD08F58728B Q36671106-43892DDE-371F-4C67-8014-B705966151C6 Q36824210-6231201C-E8F7-4005-9FE2-88DDCB2CFFFE Q36878921-C0052FCC-3C38-4E87-9E81-9EDEA8EDE4D5 Q37125722-B1BEC2B5-8D1C-41B8-AF01-871D48AF0603 Q37136824-73B92D57-7973-43E2-B1F3-087F578E1C12 Q37547107-A00CA61C-94E8-4ACB-98A1-C4191AC6F62B Q37601003-9CDFF2EB-B59F-4807-9525-E59CCF0104CA Q37611796-CBF74FB3-038B-426C-8950-3F38B58E9B48 Q37694574-2E898DAA-6072-4E49-8B2B-9E77715379BC Q38241377-DAC721B0-EE32-4497-9561-3CFECBC2DF2A Q38243160-B03BD7FA-CA11-4075-92D1-FD18D6A93A3D Q38883116-317AC0C1-AAEC-4CB0-A9E4-45787FA46AF6 Q38947443-CE7C04DE-A327-4003-8A01-8A93E0C33851 Q40210971-C19877DE-3732-47A7-8821-844D55802F61 Q40443062-B06CB12F-51F0-4E3E-A44A-0C7336AB2B9A Q45324169-2A66E576-7700-45F2-814A-EA1DA91E9A65 Q55406946-8AD67E97-1157-46D6-AB71-5D54E9699370 Q57072187-4D46187C-4058-4C04-8A93-58AB7C257BE1

P2860

Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa

http://www.wikidata.org/entity/Q35275146

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Immunization with a vaccine co ...... HSV-2 DNA in guinea pigs compa

@ast

Immunization with a vaccine co ...... HSV-2 DNA in guinea pigs compa

@en

type

label

Immunization with a vaccine co ...... HSV-2 DNA in guinea pigs compa

@ast

Immunization with a vaccine co ...... HSV-2 DNA in guinea pigs compa

@en

prefLabel

Immunization with a vaccine co ...... HSV-2 DNA in guinea pigs compa

@ast

Immunization with a vaccine co ...... HSV-2 DNA in guinea pigs compa

@en

P1433

Q35275146-9777C237-2127-4E4B-9EF0-A5C08F3D0C6A

P1476

Q35275146-CB60224D-6800-4AC8-B590-88F962AFFE9A

P2093

Q35275146-032BDCD6-618A-4CF1-AEFC-CFFD9BD0F209

Q35275146-1A352914-A467-48BA-B395-0D6B1E943531

Q35275146-2CB6F9C9-7140-4660-88E9-BDB965B02D31

Q35275146-4F5B1A8D-5202-42D3-959D-A58487F066E0

Q35275146-51B08EBA-EBD2-40DE-B2C9-02A4D5419EEB

Q35275146-53F6E77B-8816-41FC-83E6-18DA334F0152

Q35275146-55D97BF3-A816-4A61-9B34-7F797F840057

Q35275146-635FE680-9A73-4EE8-8AF9-37C60CF72488

Q35275146-825089F7-6B02-4C4A-97D0-92BB400F5464

Q35275146-97960F2E-41F7-4A3B-9436-DBBDFCBE93E1

P2860

Q35275146-02BBF749-9B80-4D33-A490-34F98CE29CE3

Q35275146-08C837E5-89EA-4BBF-A27E-8968EB35CFE9

Q35275146-0E47F1BF-37A7-43BA-92F2-D8514DA85E3C

Q35275146-11CFAA06-A0F9-47FE-9271-EB2AD879E8E4

Q35275146-1423A66F-5D3D-46C7-AB8B-CC2423C16BDE

Q35275146-1B4298FF-523B-4FF9-BA0E-4B5B9FC6307A

Q35275146-20417D51-4630-4A0B-81F8-7A1802FB2C3D

Q35275146-20DF0B37-06DC-4721-9E25-298FA5B0D4FA

Q35275146-2244EE1B-4576-4F69-8E30-10E658097BC6

Q35275146-23DED678-29FB-40B1-9017-85801649B3C2

P304

Q35275146-ABC2635A-29D5-4146-814D-07D563DB683A

P31

Q35275146-32E1D019-0D97-418A-B52B-BC52CD85B73B

P356

Q35275146-6575EB99-101B-4319-B281-3C9BF22D2232

P407

Q35275146-E2F3CA5F-B219-475C-90E1-93D9BCF1F0F3

P433

Q35275146-DF1B651D-66DE-4D60-9BFE-425284F313C0

P478

Q35275146-98611C61-EAAC-4713-BC4E-5A36A7FE79D7

P577

Q35275146-63BE1248-999B-4CAB-94AD-ACF0ADF9D666

P698

Q35275146-351C886A-43E9-4809-8A62-1D6362B9F2EF

P921

Q35275146-4C708479-688D-43A4-B0A2-4EFE7A1F18FF

P932

Q35275146-3C91DBDA-87E3-451D-B84D-39C6C40E7EBA

P356

P1433

Journal of Virology

P1476

Immunization with a vaccine co ...... HSV-2 DNA in guinea pigs compa

@en

P2093

Carolyn E Shaw

http://www.w3.org/2001/XMLSchema#string

Daniel J Distefano

http://www.w3.org/2001/XMLSchema#string

Danilo R Casimiro

http://www.w3.org/2001/XMLSchema#string

Fushan Wang

http://www.w3.org/2001/XMLSchema#string

Harvey M Friedman

http://www.w3.org/2001/XMLSchema#string

Janine T Bryan

http://www.w3.org/2001/XMLSchema#string

Jessica A Flynn

http://www.w3.org/2001/XMLSchema#string

John M Lubinski

http://www.w3.org/2001/XMLSchema#string

John W Balliet

http://www.w3.org/2001/XMLSchema#string

Michael Betts

http://www.w3.org/2001/XMLSchema#string

P2860

West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H

Protective immune responses against West Nile virus are primed by distinct complement activation pathways

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.

Murine gammaherpesvirus 68 encodes a functional regulator of complement activation

The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks.

In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

P304

10472-10486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00849-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21813597

http://www.w3.org/2001/XMLSchema#string

P921

P932

3187515

http://www.w3.org/2001/XMLSchema#string